Cardiff Oncology
CRDF
CRDF
66 hedge funds and large institutions have $42.3M invested in Cardiff Oncology in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
54% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 26
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
66
Holding in Top 10
–
Calls
$1.29M
Puts
$911K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$314K | |
| 3 | +$137K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$90K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$81K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.53M | |
| 3 | -$766K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$717K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$395K |